Data presented at ASH suggested that CDK4/6 inhibitors given with chemo for Rb-deficient tumors could mitigate the risk of secondary myeloid neoplasms.
New data presented at the 2025 ASH demonstrates 94% disease free and overall survival rate Omisirge approved by FDA as First Cell Therapy to Treat Severe Aplastic Anemia Key Highlights of Data ...
WASHINGTON – Pamela Smith, who was catapulted into national attention after President Donald Trump moved to federalize ...
Positive results of ERNA-101 in ovarian cancer models demonstrated promising survival benefit and immune activation, ...
You'll want to ensure the toy you choose is developmentally appropriate for your little one. If you pick one aimed at a ...
In a Maryland operating room one day in November 2025, doctors made medical history by transplanting a genetically modified pig kidney into a living patient. The kidney had been engineered to mimic ...
GE Vernova transformed the TODAY Plaza into Innovators Toy Land with life-size versions of STEM toys. Shop Lite-Brite and ...
Piracy costs publishers an estimated US$55 billion a year, forcing a hi-tech shift to protect a sector aiming to rival car exports by 2033.
Presented new data in non-human primates (NHP) for sickle cell disease (SCD), where RNA Gene Writer achieved approximately 40% and 60% of long-term hematopoietic stem cells (LT-HSCs) with at least one ...